A phase I study of amrubicin (AMR) and cyclophosphamide in patients with advanced solid organ malignancies: A trial from the Hoosier Oncology Group.
S. I. Jalal
No relevant relationships to disclose
J. A. Bufill
No relevant relationships to disclose
G. A. Masters
No relevant relationships to disclose
N. Somaiah
No relevant relationships to disclose
K. Koneru
No relevant relationships to disclose
J. McClean
No relevant relationships to disclose
R. E. Sanborn
No relevant relationships to disclose
J. Wu
No relevant relationships to disclose
Z. Yu
No relevant relationships to disclose
L. H. Einhorn
Consultant or Advisory Role - Celgene